Here are Top Medical stories of the dayA combination pill approved for severe acute pain in adults The US Food and Drug Administration (FDA) has approved Seglentis a combination of celecoxib and tramadol hydrochloride for severe acute pain in adults, especially when alternative treatments fail to provide adequate pain relief.It is an innovative first-in-class product comprised of a...
Here are Top Medical stories of the day
A combination pill approved for severe acute pain in adults
The US Food and Drug Administration (FDA) has approved Seglentis a combination of celecoxib and tramadol hydrochloride for severe acute pain in adults, especially when alternative treatments fail to provide adequate pain relief.
It is an innovative first-in-class product comprised of a co-crystal form of celecoxib an anti-inflammatory drug and tramadol ,an analgesic for the treatment of acute pain in adults.
For more details, check out the full story on the link below:
FDA Approves Combination Pill For Severe Acute Pain In Adults
Regular Millet consumption may improve iron deficiency Anemia, finds study
The prevalence of iron deficiency anemia is highest among low and middle-income countries where Millets, including sorghum, rich in iron are a traditional staple diet. A wide variation in the iron composition of millets has been reported, which needs to be understood in consonance with its bioavailability and roles in reducing anemia.
Regular consumption of millets can improve hemoglobin and serum ferritin levels to reduce iron deficiency anemia, finds a new study.
For more details, check out the full story on the link below:
Regular Millet Consumption May Improve Iron Deficiency Anemia, Finds Study
Novel stem cell-derived therapy for type 1 diabetes shows promising results
A stem cell-derived potential therapy VX-880 for treating Type 1 diabetes has resulted in a 91% decrease in daily insulin doses in first patient, according to a recent press release.
Vertex Pharmaceuticals Incorporated has shared results of Phase 1/2 of its clinical trial in which after only 90 days of its ongoing investigational study, the patient's insulin needs were reduced from 34 daily units down to 3 daily units.
For more details, check out the full story on the link below:
Novel Stem Cell-Derived Therapy For Type 1 Diabetes Shows Promising Results
Menstrual cycle length during menopause transition may predict risk of future atherosclerosis
Menstrual cycle length has been associated with different chronic conditions, including breast cancer, osteoporosis, and cardiovascular disease.
Changes in cycle length specifically during the menopause transition may also predict a woman's risk of developing atherosclerosis after menopause, finds a new study.
For more details, check out the full story on the link below:
Menstrual Cycle Length During Menopause Transition May Predict Risk Of Future Atherosclerosis
For more details, check out the full story on the link below:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd